Quantcast

Latest Organic chemistry Stories

2014-10-20 16:27:01

Boehringer Ingelheim launches comprehensive support resources for people with idiopathic pulmonary fibrosis RIDGEFIELD, Conn., Oct. 20, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. has announced that OFEV® (nintedanib) capsules are now commercially available in the United States. OFEV was approved by the U.S. Food and Drug Administration (FDA) on October 15, 2014 for the treatment of idiopathic pulmonary fibrosis (IPF). It is the only kinase inhibitor approved to treat...

2014-10-20 08:35:30

DUBLIN, Oct. 20, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global and Chinese Cysteine Methyl Ester Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The Global and Chinese Cysteine Methyl Ester Industry Report is a professional and in-depth study on the current state of the global cysteine methyl ester industry with a focus on the Chinese situation. The report provides a basic overview of the industry...

2014-10-20 08:32:26

WOODCLIFF LAKE, N.J., Oct. 20, 2014 /PRNewswire/ -- Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's Supplemental New Drug Application (sNDA) for its in-house-discovered AMPA receptor antagonist perampanel for the treatment of primary generalized tonic-clonic (PGTC) seizures, a severe form of seizures, in patients 12 years and older. FYCOMPA((TM)) (perampanel) CIII, which was approved by the FDA in October 2012 and became...

2014-10-18 23:01:41

The Firm is representing numerous Risperdal lawsuit plaintiffs in claims that allege the atypical antipsychotic medication caused gynecomastia, or male breast growth. New York, New York (PRWEB) October 18, 2014 Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) continue to mount in a mass tort litigation now underway in Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein Liebhard LLP reports. According to court documents, 888 product liability claims have been filed in...

2014-10-17 08:22:23

DUBLIN, Oct. 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global and Chinese Methionine Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The Global and Chinese Methionine Industry Report 2014 is a professional and in-depth study on the current state of the the global methionine industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions,...

2014-10-16 12:28:14

Launch of Novel Immune Checkpoint Inhibitors Will Fuel Market Growth and Will Dramatically Enhance RCC Treatment Algorithm, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 16, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for renal cell carcinoma (RCC) therapies will grow to approximately $2.5 billion by 2023, despite the aggressive generic erosion of Pfizer's Sutent, GlaxoSmithKline's Votrient, Pfizer's Inlyta, Bayer HealthCare/Onyx...

2014-10-16 08:31:24

Additional Capital Enable Company to Achieve Additional Milestones in its Business Plan NEW YORK, Oct. 16, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today the issuance of approximately 10.1 million of its shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with private placements that closed in May and June 2014. The warrants...

2014-10-16 08:30:45

Patent estate includes thirteen issued U.S. patents, thirty patents worldwide REDWOOD CITY, Calif., Oct. 16, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today provided an update regarding its growing patent estate which totals 30 issued patents worldwide. These issued patents cover AcelRx's sufentanil...

2014-10-15 23:01:37

New research report “Global Cancer Kinase Inhibitors Market & Pipeline Insight” elaborated by Kuick Research is now available at MarketPublishers.com. According to the study, the global kinase inhibitors market is poised to gain momentum through 2018. London, UK (PRWEB) October 15, 2014 The field of cancer is developing driven primarily by the ageing world population, soaring rates of smoking, and the growth in obesity across all geographies. This opens up a slew of nice...

2014-10-15 16:24:32

WASHINGTON, Oct. 15, 2014 /PRNewswire-USNewswire/ -- Despite a massive outpouring of public opposition, the U.S. Environmental Protection Agency (EPA) announced today that it has registered Enlist-Duo,® an herbicide that incorporates a mix of glyphosate and a new formulation of 2,4-D, intended for use on genetically engineered (GE) Enlist-Duo®-tolerant corn and soybean crops, officially ushering in the new wave of GE 2,4-D tolerant crops. "EPA approval of this herbicide sets a...


Latest Organic chemistry Reference Libraries

Organometallics
2012-05-17 15:18:17

Organometallics is a peer-reviewed scientific journal published by the American Chemical Society. As of May 2012, the editor-in-chief is John A. Gladysz. Organometallics publishes records in one of the most active fields for organometallic, inorganic, organic, and materials chemists. Articles, communications, mini-reviews, and notes detail the synthesis, structure, bonding, chemical reactivity and reaction mechanisms, and applications of organometallic and organometalloidal compounds....

Synthetic Metals
2012-05-17 14:54:38

Synthetic Metals is a peer-reviewed scientific journal published by Elsevier. It covers all aspects of electronic polymers and electronic molecular materials. It is an international medium for the rapid publication of original research papers, short communications and subject reviews dealing with research on and applications of electronic polymers and electronic molecular materials including novel carbon architectures. Original manuscripts on chemical, electrochemical, electrical, photonic...

More Articles (2 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related